Skip to main content
Caplight Logo









Abionic SA

Abionic SA

Private
EpalingesHealthcare & Life Scienceshttps://abionic.com/

Last Round

Series C

Mar 28, 2018

Total Funding Raised

$28.97M

Company Overview

Abionic SA is a medical technology company that develops and manufactures ultra-rapid in vitro diagnostic solutions using proprietary nanofluidic technology.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

point-of-care diagnosticsPOC testingnanofluidic technologyin vitro diagnosticsIVDdiagnostic platformrazor-and-blade modelclinical diagnosticsimmunoassaymedical deviceacute care diagnosticsdiagnostic cartridgesbedside testingrapid testingmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Abionic SA Comparables

Compare Abionic SA with similar companies based on industry and business-model similarity.

Abionic SA comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NanoDx
84%
Novus Diagnostics
84%
SphingoTec
82%

Abionic SA Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMar 28, 2018
Series BOct 14, 2014
Series AApr 26, 2012
AcceleratorOct 1, 2010

Key People

Founding team and executive leadership

Iwan Märki

CTO and Co-Founder

Founding Team

Patrick Pestalozzi

Chief Executive Officer

Executive Team

Abionic SA Investors

Notable investors and investment history

Abionic SA investors
InvestorRounds
Verve VenturesSeries C
Business Angels SwitzerlandSeries A
Immo DumasSeries C
Venture KickAccelerator
PolyTech VenturesSeries A
Zurcher KantonalbankSeries C
Drexel Morgan & Co.Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 9, 2025

    Monthly visitors increased 214% MoM, reaching 2.1K.

  • Mar 28, 2018

    $21M round led by Pierangelo Bottinelli.

Abionic SA Filings

Explore SEC and related filing metadata, where available.

Abionic SA filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Abionic SA's valuation, stock price, and market status.

Is Abionic SA a public or private company?

Abionic SA is a private company.

What is the current stock price of Abionic SA?

Abionic SA is a private company with no public stock price. No recent secondary market data is available.

How much is Abionic SA worth (valuation)?

Valuation information for Abionic SA is not publicly available.

Can I buy Abionic SA stock?

Abionic SA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Abionic SA's last funding round?

Abionic SA's most recent funding round was Series C on March 28, 2018.

Who are the main investors in Abionic SA?

Key investors in Abionic SA include Verve Ventures, Business Angels Switzerland, Immo Dumas, Venture Kick, PolyTech Ventures.

Will Abionic SA IPO soon?

No public IPO plans have been announced for Abionic SA.

How can I track Abionic SA secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Abionic SA's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEpalinges
Employee Range23
Year Founded2010
Last FundingMar 28, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?